National Institute Of Mental Health
-
First successful clinical trial of VU319 brings Alzheimer’s treatment one step closer
Researchers at the Warren Center for Neuroscience Drug Discovery, a clinical stage biotech within the Vanderbilt University School of Medicine Basic Sciences, have detailed the successful drug discovery of a Phase I Single Ascending Dose clinical trial of VU319, a drug for memory loss in people with Alzheimer’s disease and schizophrenia. Read MoreDec 19, 2024
-
Research snapshot: Examining the impact of negative media coverage on LGBTQ+ young adults
Kirsty Clark, assistant professor of medicine, health, and society, studies mental health disparities impacting LGBTQ+ populations through her lab. Clark recently published research that explores the effects of negative news and media coverage on the intensity of suicidal thoughts in LGBTQ+ young adults. Read MoreSep 19, 2024
-
Rubinov awarded $1.1M to study molecular underpinnings of human brain networks on a large scale
Mikail Rubinov, assistant professor of biomedical engineering, computer science, psychiatry and psychology, has been awarded a four-year, $1.1 million grant from the National Institute of Mental Health to better understand the development and organization of brain networks, as well as their change in development and aging. Rubinov and his collaborators will link aspects of gene expression and... Read MoreMar 17, 2022
-
Children with autism benefit from peer solicitation
iStock Peer solicitation – a child inviting another to play – can improve reciprocal social interaction among children with autism, according to a Vanderbilt University study released today in the Journal of Child Psychology and Psychiatry. Researchers studied playground interactions between children with autism and typically… Read MoreDec 12, 2013
-
Conte Center receives grant to study serotonin
The Silvio O. Conte Center for Neuroscience Research at Vanderbilt has received a $10.5 million federal grant to continue its groundbreaking research on serotonin signaling in the brain for another five years. Read MoreAug 30, 2012